MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma
about
P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancerActivated leukocyte cell adhesion molecule expression and shedding in thyroid tumors.Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tractRelevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells.Prognostic value of CD166 expression in cancers of the digestive system: a systematic review and meta-analysis.Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancerMCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse.Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays.Can recurrences be predicted in craniopharyngiomas? β-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases.A systematic evaluation for the potential translation of CD166-related expression as a cancer biomarker.Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer.ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients.ALCAM (CD166) is a surface marker for early murine cardiomyocytes.Cloning of the human activated leukocyte cell adhesion molecule promoter and identification of its tissue-independent transcriptional activation by Sp1.Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population.Roles of microRNAs and RNA-Binding Proteins in the Regulation of Colorectal Cancer Stem Cells.Activated leukocyte cell adhesion molecule (ALCAM/CD166) regulates T cell responses in a murine model of food allergy.Prognostic Significance of Activated Leukocyte Cell Adhesion Molecule (ALCAM) in Association with Promoter Methylation of the ALCAM Gene in Breast Cancer.Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.Characterization of cancer stem cells from different grades of human colorectal cancer.Genetic Variation in CD166 Gene and Its Association with Bladder Cancer Risk in North Indian Population.
P2860
Q27852992-31E1D52D-E107-45ED-873E-11F3EA1054D0Q33833972-78F1E946-1E88-4C72-964F-04D9F23E15F2Q34136852-9D5BA214-3134-4677-AA34-6F9DB4F53763Q34220083-BBEBA105-30B4-4EF7-94AE-251346FE31D6Q34250074-4DE51950-D6FA-4D39-AFDE-73D5BF91532CQ34321331-735CEA71-B28E-4F59-87A8-31B29959C323Q34936453-1A294D02-3F44-43D6-97E1-AFA594FA845DQ35220347-71A2E1D8-5EC0-49C3-83CE-A18A94261253Q35769956-A3FFC265-5ED4-43F7-A6F8-A9729DC369F5Q36010284-05EA9790-A704-4571-BCD4-D122FB596604Q37287549-DA306929-0679-40D8-9066-55F2F36AADCDQ37289417-9A1D96DF-F3A5-45B6-8D05-4CB7DF2D717FQ37895975-28F035A0-45C1-4DDD-92A9-3286F1B8669DQ38678576-E16A236D-0EBD-41FF-B343-707FC1214667Q39615435-1625F6CC-431A-4D93-B28D-DB8B1BB12A0FQ39640366-7EAD0F0B-0B42-4355-B7AE-A8E97027ADD2Q39647270-67181FCD-FBB5-444C-A16D-D9CCCB4FEA36Q39715463-A393E210-AF0C-43C5-829D-02C56BD85324Q40149083-1525D890-4DE7-4475-8137-29AD498465A3Q42021757-646C4C47-B0AB-47EF-AEDB-0A9AC15CE90AQ44863079-37FEA884-330A-453F-85C2-2EBF0AD941D3Q47211731-0E9644E3-23F9-45F5-9045-81F3499325B5Q47843077-0F34908F-64A7-4C4E-95A5-DE5A68ADDD75Q48284336-8D0E4795-E175-441F-B854-6393264EBCD7Q50065793-B09AFD5C-5D85-4E4C-9703-F7F26E784672Q51581224-7796EF8F-2766-4989-AF57-4DAF79E5BAF7Q54526521-666B8E33-1E9B-4ACE-835E-123CE21F3329
P2860
MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
MEMD/ALCAM: a potential marker ...... hageal squamous cell carcinoma
@ast
MEMD/ALCAM: a potential marker ...... hageal squamous cell carcinoma
@en
MEMD/ALCAM: a potential marker ...... hageal squamous cell carcinoma
@nl
type
label
MEMD/ALCAM: a potential marker ...... hageal squamous cell carcinoma
@ast
MEMD/ALCAM: a potential marker ...... hageal squamous cell carcinoma
@en
MEMD/ALCAM: a potential marker ...... hageal squamous cell carcinoma
@nl
prefLabel
MEMD/ALCAM: a potential marker ...... hageal squamous cell carcinoma
@ast
MEMD/ALCAM: a potential marker ...... hageal squamous cell carcinoma
@en
MEMD/ALCAM: a potential marker ...... hageal squamous cell carcinoma
@nl
P2093
P2860
P356
P1433
P1476
MEMD/ALCAM: a potential marker ...... hageal squamous cell carcinoma
@en
P2093
Amit Verma
Nootan Kumar Shukla
Ranju Ralhan
Siddhartha Datta Gupta
P2860
P304
P356
10.1159/000086989
P407
P577
2005-01-01T00:00:00Z